Human Genome Sciences Trades Up 4% on Q4 Results
Human Genome Sciences (NASDAQ: HGSI) released its Q4 earnings results after the closing bell on Monday. The Rockville, Maryland based biotech firm reported a Q4 loss of $0.41 on an earnings per share basis. This compared to analysts consensus EPS estimates which called for a loss of $0.43.
Revenues for the quarter were $45.50 million compared to Street consensus of $42.65 million.
In Monday's after hours trading session, HGSI shares have added 3.57% to $8.70.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.